Biogen shares soar on Alzheimer's drug developments - 1breakingnews.com

  • 2 years ago
A study found that Biogen's Alzheimer's drug lecanemab reduced cognitive and functional decline by 27% compared to a placebo over an 18-month period.

VIEW MORE : https://bit.ly/1breakingnews

Recommended